{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T17:18:33Z","timestamp":1778001513824,"version":"3.51.4"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7,1]]},"DOI":"10.1097\/aln.0b013e31828fc627","type":"journal-article","created":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T22:03:19Z","timestamp":1363989799000},"page":"191-200","source":"Crossref","is-referenced-by-count":15,"title":["Case Scenario: Management of Trauma-induced Coagulopathy in a Severe Blunt Trauma Patient"],"prefix":"10.1097","volume":"119","author":[{"given":"Jean-Stephane","family":"David","sequence":"first","affiliation":[{"name":"Professor, Department of Anesthesiology and Critical Care, Lyon Sud Hospital, Hospices Civils de Lyon, Pierre Benite and Charles Merieux School of Medicine, Universit\u00e9 Lyon 1, Oullins, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Godier","sequence":"additional","affiliation":[{"name":"Assistant Professor, Department of Anesthesiology and Critical Care, Cochin Hospital, Assistance Publique-H\u00f4pitaux de Paris, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yesim","family":"Dargaud","sequence":"additional","affiliation":[{"name":"Associate Professor, Department of Hemostasis, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France, and Lyon Est School of Medicine, Universit\u00e9 Lyon 1, Lyon, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Inaba","sequence":"additional","affiliation":[{"name":"Associate Professor, Division of Trauma and Critical Care, Department of Surgery, LAC + USC Medical Center, University of Southern California, Los Angeles, California."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"2021031821174625300_R1","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(12)61224-0","article-title":"Haemorrhage control in severely injured patients.","volume":"380","year":"2012","journal-title":"Lancet"},{"key":"2021031821174625300_R2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2141.2011.08885.x","article-title":"Management of major trauma haemorrhage: Treatment priorities and controversies.","volume":"155","year":"2011","journal-title":"Br J Haematol"},{"key":"2021031821174625300_R3","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/cc8943","article-title":"Management of bleeding following major trauma: An updated European guideline.","volume":"14","year":"2010","journal-title":"Crit Care"},{"key":"2021031821174625300_R4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/MCC.0b013e328357b209","article-title":"Resuscitation and transfusion management in trauma patients: Emerging concepts.","volume":"18","year":"2012","journal-title":"Curr Opin Crit Care"},{"key":"2021031821174625300_R5","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/j.1537-2995.2010.02630.x","article-title":"The effect of plasma transfusion on morbidity and mortality: A systematic review and meta-analysis.","volume":"50","year":"2010","journal-title":"Transfusion"},{"key":"2021031821174625300_R6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/cc8205","article-title":"Clinical review: Fresh frozen plasma in massive bleedings\u2014more questions than answers.","volume":"14","year":"2010","journal-title":"Crit Care"},{"key":"2021031821174625300_R7","first-page":"221","article-title":"Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome.","volume":"67","year":"2009","journal-title":"J Trauma"},{"key":"2021031821174625300_R8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.injury.2012.08.047","article-title":"The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma.","volume":"44","year":"2013","journal-title":"Injury"},{"key":"2021031821174625300_R9","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1186\/cc8948","article-title":"Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate.","volume":"14","year":"2010","journal-title":"Crit Care"},{"key":"2021031821174625300_R10","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/cc10078","article-title":"Transfusion in trauma: Thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy.","volume":"15","year":"2011","journal-title":"Crit Care"},{"key":"2021031821174625300_R11","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/ALN.0b013e3181f22b5a","article-title":"Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution.","volume":"113","year":"2010","journal-title":"Anesthesiology"},{"key":"2021031821174625300_R12","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1097\/CCM.0b013e3182281af5","article-title":"Functional definition and characterization of acute traumatic coagulopathy.","volume":"39","year":"2011","journal-title":"Crit Care Med"},{"key":"2021031821174625300_R13","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1111\/j.1538-7836.2010.03945.x","article-title":"Definition and drivers of acute traumatic coagulopathy: Clinical and experimental investigations.","volume":"8","year":"2010","journal-title":"J Thromb Haemost"},{"key":"2021031821174625300_R14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.tmrv.2009.09.004","article-title":"Correction of coagulation in dilutional coagulopathy: Use of kinetic and capacitive coagulation assays to improve hemostasis.","volume":"24","year":"2010","journal-title":"Transfus Med Rev"},{"key":"2021031821174625300_R15","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/TA.0b013e31822c884d","article-title":"Utility of a point-of-care device for rapid determination of prothrombin time in trauma patients: A preliminary study.","volume":"72","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"key":"2021031821174625300_R16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1538-7836.2007.02319.x","article-title":"Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography.","volume":"5","year":"2007","journal-title":"J Thromb Haemost"},{"key":"2021031821174625300_R17","first-page":"407","article-title":"Rapid thrombelastography delivers real-time results that predict transfusion within 1 hour of admission.","volume":"71","year":"2011","journal-title":"J Trauma"},{"key":"2021031821174625300_R18","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1538-7836.2012.04752.x","article-title":"Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes.","volume":"10","year":"2012","journal-title":"J Thromb Haemost"},{"key":"2021031821174625300_R19","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/bja\/aen083","article-title":"Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients.","volume":"100","year":"2008","journal-title":"Br J Anaesth"},{"key":"2021031821174625300_R20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/ALN.0b013e318220755c","article-title":"Diagnostic performance and therapeutic consequence of thromboelastometry activated by kaolin versus a panel of specific reagents.","volume":"115","year":"2011","journal-title":"Anesthesiology"},{"issue":"2 suppl 3","key":"2021031821174625300_R21","first-page":"S318","article-title":"Increased platelet: RBC ratios are associated with improved survival after massive transfusion.","volume":"71","year":"2011","journal-title":"J Trauma"},{"key":"2021031821174625300_R22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/TA.0b013e31825889ba","article-title":"Debunking the survival bias myth: Characterization of mortality during the initial 24 hours for patients requiring massive transfusion.","volume":"73","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"key":"2021031821174625300_R23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1423-0410.2011.01472.x","article-title":"Prevention and treatment of coagulopathy in patients receiving massive transfusions.","volume":"101","year":"2011","journal-title":"Vox Sang"},{"key":"2021031821174625300_R24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tmrv.2006.05.002","article-title":"Serious hazards of transfusion: A decade of hemovigilance in the UK.","volume":"20","year":"2006","journal-title":"Transfus Med Rev"},{"key":"2021031821174625300_R25","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1164\/rccm.200702-271OC","article-title":"Transfusion-related acute lung injury in the critically ill: Prospective nested case-control study.","volume":"176","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2021031821174625300_R26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1586\/17474086.1.1.99","article-title":"Transfusion medicine in trauma patients.","volume":"1","year":"2008","journal-title":"Expert Rev Hematol"},{"key":"2021031821174625300_R27","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jamcollsurg.2010.01.031","article-title":"Impact of plasma transfusion in trauma patients who do not require massive transfusion.","volume":"210","year":"2010","journal-title":"J Am Coll Surg"},{"key":"2021031821174625300_R28","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1423-0410.2009.01167.x","article-title":"Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma.","volume":"96","year":"2009","journal-title":"Vox Sang"},{"key":"2021031821174625300_R29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.injury.2010.11.003","article-title":"Early coagulopathy in trauma patients: An on-scene and hospital admission study.","volume":"43","year":"2012","journal-title":"Injury"},{"key":"2021031821174625300_R30","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1111\/j.1537-2995.2010.03050.x","article-title":"Blood product use in trauma resuscitation: Plasma deficit versus plasma ratio as predictors of mortality in trauma (CME).","volume":"51","year":"2011","journal-title":"Transfusion"},{"key":"2021031821174625300_R31","first-page":"1761","article-title":"Use of freeze-dried plasma in French intensive care unit in Afghanistan.","volume":"71","year":"2011","journal-title":"J Trauma"},{"key":"2021031821174625300_R32","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/ACO.0b013e328336ea59","article-title":"New developments in massive transfusion in trauma.","volume":"23","year":"2010","journal-title":"Curr Opin Anaesthesiol"},{"key":"2021031821174625300_R33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/bja\/aeq161","article-title":"Role of fibrinogen in trauma-induced coagulopathy.","volume":"105","year":"2010","journal-title":"Br J Anaesth"},{"key":"2021031821174625300_R34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/MBC.0b013e32834cb343","article-title":"Observational study of fibrinogen concentrate in massive hemorrhage: Evaluation of a multicenter register.","volume":"22","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2021031821174625300_R35","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1538-7836.2009.03331.x","article-title":"Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: A randomized, placebo-controlled clinical trial.","volume":"7","year":"2009","journal-title":"J Thromb Haemost"},{"key":"2021031821174625300_R36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1213\/ANE.0b013e31822e1853","article-title":"Fibrinogen and hemostasis: A primary hemostatic target for the management of acquired bleeding.","volume":"114","year":"2012","journal-title":"Anesth Analg"},{"key":"2021031821174625300_R37","first-page":"360","article-title":"Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates.","volume":"81","year":"1995","journal-title":"Anesth Analg"},{"key":"2021031821174625300_R38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.injury.2010.12.015","article-title":"The impact of fresh frozen plasma vs. coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion.","volume":"42","year":"2011","journal-title":"Injury"},{"key":"2021031821174625300_R39","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/j.1742-1241.2008.01859.x","article-title":"Biochemical comparison of seven commercially available prothrombin complex concentrates.","volume":"62","year":"2008","journal-title":"Int J Clin Pract"},{"key":"2021031821174625300_R40","first-page":"1151","article-title":"Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model.","volume":"68","year":"2010","journal-title":"J Trauma"},{"key":"2021031821174625300_R41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/cc9311","article-title":"Clinical review: Prothrombin complex concentrates\u2014evaluation of safety and thrombogenicity.","volume":"15","year":"2011","journal-title":"Crit Care"},{"key":"2021031821174625300_R42","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1182\/blood-2011-03-343046","article-title":"Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury.","volume":"118","year":"2011","journal-title":"Blood"},{"key":"2021031821174625300_R43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.mbc.0000114437.81125.2b","article-title":"Identification of prothrombin as a major thrombogenic agent in prothrombin complex concentrates.","volume":"15","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2021031821174625300_R44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/ACO.0b013e3283509675","article-title":"Acute traumatic coagulopathy.","volume":"25","year":"2012","journal-title":"Curr Opin Anaesthesiol"},{"key":"2021031821174625300_R45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0140-6736(10)60939-7","article-title":"Antifibrinolytic therapy: New data and new concepts.","volume":"376","year":"2010","journal-title":"Lancet"},{"key":"2021031821174625300_R46","article-title":"Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.","volume":"CD001886","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2021031821174625300_R47","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/ALN.0b013e318210f9e3","article-title":"Intraoperative tranexamic acid reduces blood transfusion in children undergoing craniosynostosis surgery: A randomized double-blind study.","volume":"114","year":"2011","journal-title":"Anesthesiology"},{"key":"2021031821174625300_R48","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(11)60317-6","article-title":"Effect of consent rituals on mortality in emergency care research.","volume":"377","year":"2011","journal-title":"Lancet"},{"key":"2021031821174625300_R49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial.","volume":"376","year":"2010","journal-title":"Lancet"},{"key":"2021031821174625300_R50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archsurg.2011.287","article-title":"Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study.","volume":"147","year":"2012","journal-title":"Arch Surg"},{"key":"2021031821174625300_R51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.TA.0000171453.37949.B7","article-title":"Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo-controlled, double-blind clinical trials.","volume":"59","year":"2005","journal-title":"J Trauma"},{"key":"2021031821174625300_R52","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-154-8-201104190-00004","article-title":"Systematic review: Benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications.","volume":"154","year":"2011","journal-title":"Ann Intern Med"},{"key":"2021031821174625300_R53","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1006221","article-title":"Safety of recombinant activated factor VII in randomized clinical trials.","volume":"363","year":"2010","journal-title":"N Engl J Med"},{"key":"2021031821174625300_R54","first-page":"179","article-title":"The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy.","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2021031821174625300_R55","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2125.2011.04060.x","article-title":"New anticoagulants: How to deal with treatment failure and bleeding complications.","volume":"72","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"2021031821174625300_R56","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMc1111095","article-title":"Acutely injured patients on dabigatran.","volume":"365","year":"2011","journal-title":"N Engl J Med"},{"key":"2021031821174625300_R57","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/ALN.0b013e3181ebdb15","article-title":"Novel oral anticoagulants: Implications in the perioperative setting.","volume":"113","year":"2010","journal-title":"Anesthesiology"},{"key":"2021031821174625300_R58","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/TA.0b013e31827019c9","article-title":"Management of dabigatran-induced anticoagulation in trauma and acute care surgery patients.","volume":"73","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"issue":"suppl 1","key":"2021031821174625300_R59","first-page":"S141","article-title":"Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors.","volume":"87","year":"2012","journal-title":"Am J Hematol"},{"key":"2021031821174625300_R60","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1160\/TH12-03-0179","article-title":"Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: A randomised crossover ex vivo study in healthy volunteers.","volume":"108","year":"2012","journal-title":"Thromb Haemost"}],"container-title":["Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pubs.asahq.org\/anesthesiology\/article-pdf\/119\/1\/191\/261763\/20130700_0-00031.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.lww.com\/10.1097\/ALN.0b013e31828fc627","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T16:48:09Z","timestamp":1735922889000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ALN.0b013e31828fc627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7,1]]}},"URL":"https:\/\/doi.org\/10.1097\/aln.0b013e31828fc627","relation":{},"ISSN":["0003-3022"],"issn-type":[{"value":"0003-3022","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7,1]]}}}